Abstract
Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
Keywords: Carotid artery stenosis, statins, antiplatelet agents, hypertension, risk factors, diagnosis
Current Vascular Pharmacology
Title: ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis
Volume: 8 Issue: 5
Author(s): Christos D. Liapis, Sir Peter F. Bell, Dimitri P. Mikhailidis, Juhani Sivenius, Andrew Nicolaides, Jose Fernandes e Fernandes, Giorgio Biasi, Lars Norgren and ESVS Guidelines Collaborators
Affiliation:
Keywords: Carotid artery stenosis, statins, antiplatelet agents, hypertension, risk factors, diagnosis
Abstract: Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
Export Options
About this article
Cite this article as:
D. Liapis Christos, Peter F. Bell Sir, P. Mikhailidis Dimitri, Sivenius Juhani, Nicolaides Andrew, Fernandes e Fernandes Jose, Biasi Giorgio, Norgren Lars and Guidelines Collaborators ESVS, ESVS Guidelines: Section B - Diagnosis and Investigation of Patients with Carotid Stenosis, Current Vascular Pharmacology 2010; 8 (5) . https://dx.doi.org/10.2174/157016110792006888
DOI https://dx.doi.org/10.2174/157016110792006888 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Need for an Interdisciplinary Network of Investigations on HHT
Current Pharmaceutical Design Cerebroprotective Functions of HO-2
Current Pharmaceutical Design Arterial Dilatation-Related Diseases: The Prerequisite Condition of Arterial Elastic Tissue Damage and Endovascular Treatment
Recent Patents on Medical Imaging Anomalous Vascular Supply of Bronchial Circulation in Cystic Fibrosis Patients with Massive Hemoptysis
Current Respiratory Medicine Reviews A Survey on Synthesis Processes of Structured Materials for Biomedical Applications: Iron-based Magnetic Nanoparticles, Polymeric Materials and Polymerization Processes
Current Pharmaceutical Design Pathogenesis and Subtype of Intracerebral Hemorrhage (ICH) and ICH Score Determines Prognosis
Current Neurovascular Research Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science Multigate Quality Doppler Profiles and Morphological/Hemodynamic Alterations in Multiple Sclerosis Patients
Current Neurovascular Research HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research The Effect of Chemotherapy/Radiotherapy on Cancerous Pattern Recognition by NK Cells
Current Medicinal Chemistry A Review of Artificial Intelligence in Cerebrovascular Disease Imaging: Applications and Challenges
Current Neuropharmacology Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
Current Pharmaceutical Design Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery
Current Drug Targets Ablation of T-Helper 1 Cell Derived Cytokines and of Monocyte-Derived Tumor Necrosis Factor-α in Hereditary Hemorrhagic Telangiectasia: Immunological Consequences and Clinical Considerations
Current Pharmaceutical Design From Cerebrospinal Fluid Pulsation to Noninvasive Intracranial Compliance and Pressure Measured by MRI Flow Studies
Current Medical Imaging Cutaneomeningospinal Angiomatosis (Cobb Syndrome) in a Young Patient
CNS & Neurological Disorders - Drug Targets Injecting Illicit Substances Epidemic and Infective Endocarditis
Infectious Disorders - Drug Targets PDE4D Gene in the STRK1 Region on 5q12: Susceptibility Gene for Ischemic Stroke
Current Medicinal Chemistry Anatomical Approach to Clinical Problems of Popliteal Fossa
Current Rheumatology Reviews Optical Imaging of Microvascular Morphology and Perfusion
Current Angiogenesis (Discontinued)